Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001697496 | SCV000720140 | likely benign | not provided | 2021-04-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000864766 | SCV001005619 | likely benign | Alstrom syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002384334 | SCV002694173 | likely benign | Cardiovascular phenotype | 2020-10-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV000864766 | SCV002801771 | likely benign | Alstrom syndrome | 2021-11-24 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000864766 | SCV003799826 | likely benign | Alstrom syndrome | 2022-03-08 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330824 | SCV004038197 | likely benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001697496 | SCV004155001 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | ALMS1: BP4, BP7 |